Header Logo

Connection

Richard Pietras to Erlotinib Hydrochloride

Back to Details
This is a "connection" page, showing publications Richard Pietras has written about Erlotinib Hydrochloride.
Richard Pietras
Connection Strength
0.596
Erlotinib Hydrochloride
  1. Randomized phase II study of fulvestrant and erlotinib compared with erlotinib alone in patients with advanced or metastatic non-small cell lung cancer. Lung Cancer. 2018 09; 123:91-98.
    View in: PubMed
    Score: 0.596
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.